123 related articles for article (PubMed ID: 30608147)
1. Non-Anticoagulant Low Molecular Weight Heparins for Pharmaceutical Applications.
Ouyang Y; Yu Y; Zhang F; Chen J; Han X; Xia K; Yao Y; Zhang Z; Linhardt RJ
J Med Chem; 2019 Jan; 62(2):1067-1073. PubMed ID: 30608147
[TBL] [Abstract][Full Text] [Related]
2. Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.
Alekseeva A; Casu B; Cassinelli G; Guerrini M; Torri G; Naggi A
Anal Bioanal Chem; 2014 Jan; 406(1):249-65. PubMed ID: 24253408
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.
Li G; Yang B; Li L; Zhang F; Xue C; Linhardt RJ
Anal Biochem; 2014 Jun; 455():3-9. PubMed ID: 24680753
[TBL] [Abstract][Full Text] [Related]
4. Qualitative and quantitative analysis of heparin and low molecular weight heparins using size exclusion chromatography with multiple angle laser scattering/refractive index and inductively coupled plasma/mass spectrometry detectors.
Ouyang Y; Zeng Y; Yi L; Tang H; Li D; Linhardt RJ; Zhang Z
J Chromatogr A; 2017 Nov; 1522():56-61. PubMed ID: 28958760
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of slit protein interactions with the heparan sulphate proteoglycan glypican-1: potential agents for the treatment of spinal cord injury.
Lau E; Margolis RU
Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):417-21. PubMed ID: 19843094
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Low-Molecular-Weight Heparins by Strong Anion-Exchange Chromatography.
Sadowski R; Gadzała-Kopciuch R; Kowalkowski T; Widomski P; Jujeczka L; Buszewski B
J AOAC Int; 2017 Nov; 100(6):1706-1714. PubMed ID: 28707621
[TBL] [Abstract][Full Text] [Related]
7. Liquid chromatography-diode array detection-mass spectrometry for compositional analysis of low molecular weight heparins.
Wang Z; Li D; Sun X; Bai X; Jin L; Chi L
Anal Biochem; 2014 Apr; 451():35-41. PubMed ID: 24530286
[TBL] [Abstract][Full Text] [Related]
8. Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides.
Alekseeva A; Casu B; Torri G; Pierro S; Naggi A
Anal Biochem; 2013 Mar; 434(1):112-22. PubMed ID: 23201389
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of enoxaparin reducing end amino sugars to periodate oxidation.
Alekseeva A; Elli S; Cosentino C; Torri G; Naggi A
Carbohydr Res; 2014 Dec; 400():33-43. PubMed ID: 25457608
[TBL] [Abstract][Full Text] [Related]
10. Retention of antilipemic activity by periodate-oxidized non-anticoagulant heparins.
Casu B; Diamantini G; Fedeli G; Mantovani M; Oreste P; Pescador R; Porta R; Prino G; Torri G; Zoppetti G
Arzneimittelforschung; 1986 Apr; 36(4):637-42. PubMed ID: 3013215
[TBL] [Abstract][Full Text] [Related]
11. The Use of ITC and the Software AFFINImeter for the Quantification of the Anticoagulant Pentasaccharide in Low Molecular Weight Heparin.
Muñoz E; Sabín J
Methods Mol Biol; 2019; 1964():215-223. PubMed ID: 30929245
[TBL] [Abstract][Full Text] [Related]
12. [Is there a difference between low-molecular-weight heparins?].
Eritsland J
Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2802-3. PubMed ID: 16244685
[TBL] [Abstract][Full Text] [Related]
13. Protamine neutralisation of low molecular weight heparins and their oligosaccharide components.
Schroeder M; Hogwood J; Gray E; Mulloy B; Hackett AM; Johansen KB
Anal Bioanal Chem; 2011 Jan; 399(2):763-71. PubMed ID: 20922518
[TBL] [Abstract][Full Text] [Related]
14. Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.
Bisio A; Vecchietti D; Citterio L; Guerrini M; Raman R; Bertini S; Eisele G; Naggi A; Sasisekharan R; Torri G
Thromb Haemost; 2009 Nov; 102(5):865-73. PubMed ID: 19888521
[TBL] [Abstract][Full Text] [Related]
15. Nuclear magnetic resonance spectroscopy as a tool for the quantitative analysis of water and ions in pharmaceuticals: Example of heparin.
Monakhova YB; Diehl BWK
J Pharm Biomed Anal; 2018 May; 154():332-338. PubMed ID: 29571131
[TBL] [Abstract][Full Text] [Related]
16. Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site.
Islam T; Butler M; Sikkander SA; Toida T; Linhardt RJ
Carbohydr Res; 2002 Nov; 337(21-23):2239-43. PubMed ID: 12433488
[TBL] [Abstract][Full Text] [Related]
17. Hydrophilic interaction chromatography-multiple reaction monitoring mass spectrometry method for basic building block analysis of low molecular weight heparins prepared through nitrous acid depolymerization.
Sun X; Guo Z; Yu M; Lin C; Sheng A; Wang Z; Linhardt RJ; Chi L
J Chromatogr A; 2017 Jan; 1479():121-128. PubMed ID: 27923477
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Low-Molecular-Weight Heparins Prepared From Bovine Lung Heparin and Porcine Intestine Heparin.
Guan Y; Xu X; Liu X; Sheng A; Jin L; Linhardt RJ; Chi L
J Pharm Sci; 2016 Jun; 105(6):1843-1850. PubMed ID: 27238483
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing the anticoagulant activity of ultra-low-molecular-weight heparins using N-acetylglucosamine 6-sulfatase.
Zhou X; Li L; Linhardt RJ; Liu J
FEBS J; 2013 May; 280(10):2523-32. PubMed ID: 23374371
[TBL] [Abstract][Full Text] [Related]
20. Fragment profiling of low molecular weight heparins using reversed phase ion pair liquid chromatography-electrospray mass spectrometry.
Xu X; Li D; Chi L; Du X; Bai X; Chi L
Carbohydr Res; 2015 Apr; 407():26-33. PubMed ID: 25701653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
